
IBMS-accredited BSc (Hons) Biomedical Science graduate from the University of Roehampton, on track for a 2:1, with proven independent research experience at dissertation level under PhD supervision. Conducted a full immunological research project investigating LPS-induced pro-inflammatory cytokine secretion (TNF-α and IL-6) in U937 monocytic cells using ELISA, developing competency in mammalian cell culture, quantitative assay technique, experimental design, data analysis, and rigorous laboratory documentation. Motivated by a long-term goal of contributing to infectious disease research including HIV cure strategies, and deeply committed to developing technical expertise in a world-class research environment. The MRC Laboratory of Medical Sciences represents the ideal next step: a structured two-year programme that will build the advanced molecular and cellular biology skills including proteomics and metabolomics that form the foundation of cutting-edge biomedical discovery.
Title: The Effect of Escherichia coli LPS on cytokine (TNF-a and IL-6) secretion in U937 cells: a time course analysis
Research Question: How does Lipopolysaccharide (LPS) from Gram-negative bacteria induce cytokine production in U937 cells?
Conducted an independent immunological research project investigating the effect of E coli-derived
lipopolysaccharide (LPS) on TNF-α and IL-6 secretion in undifferentiated and PMA-differentiated U937 monocytic
cells across a 0-3 hour time course This was a full research workflow from hypothesis to written dissertation
Cell culture and maintenance: U937 monocytic cells cultured at 37°C in 5% CO2 in RPMI 1640 / 10% heat-inactivated FBS / 1% antibiotic-antimycotic in a Class II biosafety cabinet Strict aseptic technique
throughout Heat inactivation chosen deliberately to remove FBS complement activity that skews cytokine baselines — demonstrating understanding of how media composition affects experimental outcomes
PMA-induced differentiation: U937 monocytes differentiated into macrophage-like cells using 1µg/mL PMA for 24 hours Differentiation confirmed by light microscopy (increased adhesion, cytoplasmic granularity, morphological change) Demonstrated that media additives fundamentally reprogram cellular phenotype and downstream responses
Cell viability assessment: Trypan blue exclusion using Neubauer haemocytometer; experiments only proceeded at >95% viability (confirmed across duplicate counts) Cell count increased 18-fold from 4x105 to 72x105 over 48 hours (p
Reagent preparation: All ELISA reagents prepared from scratch — PBS-Tween wash buffer (raw materials, pH adjusted to 72), coatng solutions, blocking buffers, 7-point serial dilution standard curves, QC samples PMA and LPS dissolved in DMSO to defined stock concentrations before working dilutions Accurate weighing, dilution, labelling throughout
ELISA execution: Full sandwich ELISA for TNF-α and IL-6 using Ready-SET-GO kits (Fisher Scientific) Coating, blocking, standard/sample addition, detection antibody, HRP-avidin, TMB substrate, stop solution, absorbance at 450nm by microplate reader All steps per manufacturer's SOP with strict timing and temperature
control
Statistical analysis: GraphPad Prism v11 Unpaired t-test (Welch's correction) for 0 vs 24h PMA comparison; one-way ANOVA with Dunnett's multiple comparisons for time course within groups; two-way ANOVA with Sidak's correction for differentiated vs undifferentiated comparison Deliberate analytical choices explained and justified in dissertation
Key findings: PMA differentiation amplified TNF-α response 684-fold relative to undifferentiated cells (673 vs 98 pg/mL at 3 hours, p < 00001 Demonstrating that cellular state is a crucial determinant of innate immune activation magnitude
Documentation and compliance: Full Ethics Form and Risk Assessment completed and filed COSHH compliance throughout — biological waste (human-derived cells), chemical waste (DMSO, HCl, TMB, LPS, PMA), sharps handling Contemporaneous data recording, 10 results tables, 7 figures, full raw data appendices 8,773-word written scientific report produced
- BSc Biological Science, 2:1 or above, awarded 2023 or later: IBMS-accredited BSc (Hons) Biomedical
Science, University of Roehampton, on track for 2:1, graduating 2026.
- Previous experience in a laboratory research environment: Independent dissertation research project
(2025-2026) under PhD supervision — U937 cell culture, PMA-induced differentiation, LPS stimulation, ELISA cytokine quantification, statistical analysis. Plus three years of laboratory practicals across microbiology,
histopathology, molecular biology, and clinical biochemistry.
- Knowledge of biology, computing, and standard molecular/cellular techniques: ELISA, mammalian cell culture, aseptic technique, gel electrophoresis, histopathology, clinical biochemistry assays, microscopy, PCR principles, trypan blue cell viability. GraphPad Prism v11 (ANOVA, t-tests), Microsoft Office Suite.
- Knowledge of common software tools: Microsoft Word, Excel, PowerPoint; GraphPad Prism v11 for statistical analysis (unpaired t-test with Welch's correction, one-way ANOVA with Dunnett's correction, two-way ANOVA with Sidak's correction); laboratory data management throughout degree.
- Strong interest in medical, health, and experimental research: Long-term goal is to contribute to HIV cure research through a Masters in Medical and Molecular Virology followed by a PhD. This programme is a deliberate, considered step in a defined scientific career trajectory.
- Strong interest in research fields related to the hosting facility: Proteomics and metabolomics are directly relevant to HIV pathogenesis research — protein-level analysis of host-virus interactions and metabolic reprogramming in infected macrophages. Genuine scientific motivation to develop expertise in these disciplines.